Comparative studies on pharmacokinetic fates of tetrahydropalmatine enantiomers in different chemical environments in rats

Chirality

Volumn 20, Issue 2, 2008, Pages 119-124

  Hong, Zhanying ^a   Le, Jian ^b   Lin, Mei ^b   Fan, Guorong ^a   Chai, Yifeng ^a   Yin, Xueping ^a   Wu, Yutian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI INSTITUTE FOR FOOD AND DRUG CONTROL   (China)

Author keywords

Pharmacokinetics; Prescription Yuanhu Baizhi extracts; Rhizoma corydalis (Yuanhu); Tetrahydropalmatine enantiomers

Indexed keywords

ANGELICA ROOT; TETRAHYDROPALMATINE;

ANGELICA; ANIMAL EXPERIMENT; ARTICLE; CHEMICAL ENVIRONMENT; CHIRALITY; COMPARATIVE STUDY; CONTROLLED STUDY; CORYDALIS; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RACEMIC MIXTURE; RAT; SINGLE DRUG DOSE; SPRAGUE DAWLEY RAT; STEREOCHEMISTRY;

ABSORPTION; ADMINISTRATION, ORAL; ANGELICA; ANIMALS; BERBERINE ALKALOIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORYDALIS; DRUGS, CHINESE HERBAL; ETHANOL; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; STEREOISOMERISM;

EID: 38549121938     PISSN: 08990042     EISSN: 1520636X     Source Type: Journal    
DOI: 10.1002/chir.20507     Document Type: Article

References (18)

1. Pharmacopoeia Commission of RPC. Chinese pharmacopoeia, Part I. Beijing: Chemical Industry Press; 2005. p 94.
2. Kaneko H, Naruto S. Studies on the constituents of Corydalis sp. alkaloids from Chinese corydalis and the identity of D- corydamine with D-corybulbine. J Org Chem 1969;34:2803-2805.
3. Fu XY, Liang WZ, Tu GT. Chemical studies on alkaloids in Rhizoma corydalis from Zhejiang Dongyang. Acta Pharm Sin 1986;21:447-453.
4. Wu TS, Leu YL, Kuoh CS, Lee KH. Cytotoxic principles from Saussurea lappa and Corydalis turtshaninovii f. yanhusuo. J Chin Chem Soc 1997;44:357-359.
5. Xiang H, Wang ZT, Yu GD, Ruan BF, Li J. Alkaloids from Rhizoma corydalis. J Chin Pharm Univ 2002;33:483-486.
6. Sha S. Assay methods for active components in Chinese herb medicines. Beijing: The People's Medical Publishing House; 1985. p 53-54.
7. Jin GZ. Advances in pharmacological study of (-)-tetrahydropalmatine and its analogs. Acta Pharm Sin 1987;22:472-474.
8. Hong ZY, Fan GR, Chai YF, Yin XP, Wen J, Wu YT. Chiral liquid chromatography resolution and stereoselective pharmacokinetic study of tetrahydropalmatine enantiomers in dogs. J Chromatogr B 2005;826:108-113.
9. Hong ZY, Fan GR, Chai YF, Yin XP, Wu YT. Stereoselective pharmacokinetics of tetrahydropalmatine after oral administration of (-)-enantiomer and the racemate. Chirality 2005;17:293-296.
10. Pharmacopoeia Commission of RPC. Chinese pharmacopoeia, Part I. Beijing: Chemical Industry Press; 2005. p 69-70.
11. Xu S, Hu JH, Quan SC. Review about the studies on the chemical constituents and clinical usage of Radix Angelicae dahuricae. Chin Pharm 2005;16:467-469.
12. Pharmacopoeia Commission of RPC. Chinese pharmacopoeia, Part I. Beijing: Chemical Industry Press; 2005. p 362.
13. De Smet PA, Brouwers JR. Pharmacokinetic evaluation of herbal remedies basic introduction, applicability, current status and regulatory needs. Clin Pharmacokinet 1997:32:426-427.
14. De Smet PA, River L. A general outlook on ethnopharmacology. J Ethnopharmacol 1989;25:127-138.
15. Zhu YY, Yu BY. Comparative studies on chemistry and pharmacodynamics of the compatibility of Yuanhu Zhitong prescription. J Chin Pharm Univ 2003;34:461-464.
16. Inhibara K, Kushida H, Yuzurihara M, Wakui Y, Yanagisawa T, Kamei H, Ohmori S, Kitada M. Interaction of drugs and Chinese herbs: pharmaco kinetic changes of tolbutamide and diazepam caused by extract of Angelica daburica. J Pharm Pharmacol 2000;52:1023-1029.
17. Guo LQ, Taniguchi M, Chen QY, Baba K, Yamazoe Y. Inhibitory potential of herbal medicines on human cytochrome P450-mediated oxidation: properties of umbelliferous of citrus crude drugs and their relative prescriptions. Jpn J Pharmacol 2001;85:399-408.
18. Guo LQ, Taniguchi M, Xiao YQ, Baba K, Ohta T, Yamazoe Y. Inhibitory effect of natural furanocumarins on human microsomal cytochrome P450. Jpn J Pharmacol 2000;82:122-129.